We believe in – and have seen firsthand many times over – the power of innovation to positively transform health and well-being. That’s why we actively support research and development into scientific breakthroughs that can help solve the world’s most challenging problems.
The story of how a life-saving vaccine called PCV was rolled out to every child in India—in record time, at low cost, and during a pandemic—illustrates what’s possible in global…
The extensive research and development behind the breakthrough new malaria vaccine is informing work on a new generation of complementary tools to control, prevent, and ultimately eradicate malaria.
CEO Mark Suzman explains how equitable global access to COVID-19 vaccines can coexist with intellectual property protections for vaccine-producing companies.
Dr. Mike McCune, head of the foundation’s HIV Frontiers Program, details a groundbreaking new partnership with Novartis to develop affordable, single-dose gene therapies for people infected with sickle cell disease…
Andrew Trister, deputy director of Digital Health and Innovation at the Bill & Melinda Gates Foundation, shares how programmers and technologists are developing tools that track and test for COVID-19.
Trevor Mundel provides an update on the COVID-19 Therapeutics Accelerator’s progress in research, manufacturing, and testing. Mundel leads the foundation’s efforts to develop high-impact interventions against the leading causes of…
Developing and manufacturing a vaccine against COVID-19 is only part of the solution. Coordination, political will, and the infrastructure to support equitable vaccine is distribution will be essential to the…
Dr. Toni Hoover, director of Strategy, Planning, and Management for Global Health at the Gates Foundation, shares what the CoVig Alliance means for the wider fight against COVID-19—and the foundation’s…
CEO Mark Suzman reflects on the foundation’s unique position to respond to the COVID-19 crisis and shares an update on the foundation’s more than $250 million commitment to funding response…
